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Abstract 
 
Software that is incorporated into a medical device, or which is a standalone medical device in 
its own right, is of a safety critical nature and subject to regulation from various jurisdictions 
(principally the EU and the US). In order to satisfy jurisdictional regulations, developers of 
medical device software generally implement standards and guidance provided by internation-
al standards bodies and national administrative departments. However, the various standards 
and guidance documents are not developed as a single cohesive set but often as separate re-
sources addressing distinct areas of concern. The result for medical device software develop-
ers is that integration of these various sources represents a challenging undertaking. 
The aim of this paper is to describe the integration of the several process models and regula-
tory standards, first, into a process reference model and then into a process assessment 
model for medical device software development. The focus is on the integration of regulatory 
standards from the medical device domain with generic software development process mod-
els, resulting in a unified best practice framework for medical device software development. 
The process reference model for medical device software development is going to be pub-
lished this year as IEC TR 80002-3, and the process assessment model for medical device 
software development is currently being validated through pilot studies in medical device in-
dustry.  
This best practice framework will help small software developers in their adoption of regula-
tions-compliant best practices while reducing the overhead associated with understanding the 
long list of regulations and standards they need to adhere to when developing software for 
medical devices. This framework will also help the manufacturers in selecting their software 
suppliers assuring that the suppliers have adopted the best practices and are compliant with 
the medical device standards and regulations.  
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1 Introduction 
A basic requirement of the design of a medical device software process is that it satisfies the 
regulatory demands associated with the medical devices under construction; as failure to satisfy 
regulation in a particular region will mean that the device cannot be placed upon the market. In a 
sense, this is similar to the basic requirement of a software development process: that the process 
should fit the needs of the project [1]. However, in practice the realisation of this basic requirement has 
proven to be difficult to achieve in the general software engineering domain. Consequently, many 
software development approaches have been proposed and implemented, resulting in much 
discussion regarding the benefits and limitations of the various approaches [2]. It therefore seems 
likely that no single software approach should be universally prescribed for the general practice of 
software development. This is essentially owing to the complex interplay between people and the 
economic activity of commercial software development.  
1.1 Medical device regulations and standards 
A medical device can consist entirely of software or have software as a component of the overall 
medical device system. In order to be able to market a medical device within a particular region it  is 
necessary to comply with the regulatory demands of that region. Two of the largest global bodies 
responsible for issuing and managing medical device regulation belong to the central governing 
functions of the US and EU. In the case of the US, the Food and Drug Administration (FDA) issues the 
pertinent regulation through a series official channels, including the Code of Federal Regulation (CFR) 
Title 21, Chapter I, Subchapter H, Part 820 [3]. Under US regulation, there are three medical device 
safety classifications: Class I, Class II and Class III. The medical device safety classification is based 
on the clinical safety of the device. Class I devices are not intended to support or sustain human life, 
and may not present an unreasonable risk of harm. Class II devices could cause damage or harm to 
humans. An example of a Class II medical device is a powered wheelchair. Class III medical devices 
are usually those that support or sustain human life, and are of significant importance in the prevention 
of human health impairment. An example of a Class III device is an implantable pacemaker. All 
implantable devices are Class III medical devices as the surgery required carries with itself additional 
high risks from anaesthesia and possible infections that go beyond the technical and engineering 
safety risks of the correct performance of the device.  
In the EU, the corresponding regulation is outlined in the general Medical Device Directive (MDD) 
93/42/EEC [4], the Active Implantable Medical Device Directive (AIMDD) 90/385/EEC [5], and the In-
vitro Diagnostic (IVD) Medical Device Directive 98/79/EC [6] - all three of which have been amended 
by 2007/47/EC [7]. Although slightly different to the US safety classifications that are based on clinical 
safety of the device, the EU classifications essentially embody similar classifications and limitations, 
where Class I corresponds to Class I, Class IIa and IIb to Class II, and Class III to Class III. A further 
safety classification applies to the software in the medical device as outlined in IEC 62304, wherein 
the safety classification is concerned with the worst possible consequence in the case of a software 
failure (as compared with general medical device safety classification which is based on the difficulty 
of a regulator to determine if the device will be safe). Hence, some Class II medical devices can cause 
serious injury or even death, but they are Class II because they are similar (in clinical use and safety) 
to well understood devices that have been used before. Since IEC 62304 safety classifications are 
based on worse case failure of the software, it is possible that Class II medical devices can have 
Class III software. 
In the medical device domain, ISO 13485:2003 (ISO 13485 from hereon) [8] outlines the requirements 
for regulatory purposes from a QMS perspective. ISO 13485, which is based on ISO 9001 [9], can be 
used to assess an organisation’s ability to meet both customer and regulatory requirements. However, 
ISO 13485 does not offer specific guidance on medical device software development. IEC 62304:2006 
(IEC 62304 from hereon) [10], which can be used in conjunction with ISO 13485, does offer a 
framework for the lifecycle processes necessary for the safe design and maintenance of medical 
device software. As a basic foundation, IEC 62304 assumes that medical device software is 
developed and maintained within a QMS such as ISO 13485, but does not require an organisation to 
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be certified in ISO 13485. Therefore, IEC 62304 can be considered to be a software development 
specific supplement to ISO 13485. 
IEC 62304 is based on ISO/IEC 12207:1995 [11] which although a comprehensive standard for 
software development lifecycle processes has effectively been decommissioned following the 
publication of the more extensive ISO/IEC 12207:2008 [12]. Furthermore, other developments in the 
ISO and IEC communities for software development, such as ISO/IEC 15504 [13], have provided 
significant additional levels of software process detail to support ISO/IEC 12207:2008. IEC 62304 is 
currently being revised to better align with ISO/IEC 12207:2008. IEC 62304 is a critical standard for 
medical device software developers as it is the only standard that provides recommendations for 
medical device software implementations based on the worst consequences in the case the software 
failure causing hazards. Furthermore, for general medical device risk management, IEC 62304 is used 
in conjunction with ISO 14971 [14], with IEC 80002-1 [15] providing guidance on the application of ISO 
14971 for software development. Additionally, as IEC 62304 considers a medical device system to 
consist of software as part of an overall medical device system, the system level requirements are not 
included within IEC 62304 but instead within the medical device product standard IEC 60601-1 [16]. 
Also it should be noted that due to the increasing importance of usability within the medical device 
industry organisations should also adhere to the medical device usability requirements outlined in IEC 
62366 [17]. 
Numerous different medical device standards and regulations now exist, some of which are interlinked 
with generic software development standards and others which are inconsistent. The dominant 
medical device software standards such as IEC 62304 are not yet aligned with the approach adopted 
in the general software development standards community since the 1995 publication of ISO/IEC 
12207. One significant change in this respect has been the introduction of a harmonised approach to 
process description (as defined in ISO/IEC 24774 [18]) which involves the identification of core 
process outcomes that can later be harnessed to develop a process assessment method. A further 
significant change relates to the movement in the general software development standards community 
(and in other safety-related domains) to include a software process improvement dimension that can 
be instrumental in guiding software development organisations towards the required process targets. 
In effect, the medical device standards have not kept up with the changes that have been made to the 
general software development standards. There are several reasons why the medical device 
standards lag the updates to the general software development standards, (perhaps) most importantly 
the IEC stability period during which adopted harmonised standards are not to be changed unless the 
proposed changes are necessary in terms of safety. With the expanding role of software in medical 
devices, there is a case to be made for introducing the accumulated up-to-date wisdom in the general 
software development standards into the medical device software development specific standards in a 
uniform fashion – and work in this direction should not wait for the IEC stability period to come to an 
end, but rather proceed in the interim period (such as the work reported upon in this paper).  
In order to identify an appropriate architecture for introducing the significant body of general software 
process knowledge into the medical device process domain, an initial important step involves the 
building of a process reference model (PRM) for medical device software development. The approach 
used for the PRM development is described in the next section. We then illustrate the architecture and 
the challenging task of integrating various regulatory standards and informative guidance into a 
process assessment model (PAM) to allow consistent evaluation of medical device software 
development processes against the set of standards these organisations have to adhere to. Finally, 
we summarize the paper along with some concluding remarks. 
2 Development of the PRM 
A process reference model (PRM) describes a set of processes in a structured manner through a 
process name, process purpose and process outcomes. Process outcomes are the normative 
requirements the process should satisfy to achieve the purpose of the process. The PRM for medical 
device software development is based on various international medical device and generic software 
development standards as shown on Figure 1.  
The development of the PRM was carried out in two steps. In the first step, the PRM for medical 
device software life cycle processes described in IEC 62304 was developed, entitled IEC 80002-3 
which is currently under national ballot at IEC. This PRM was a result of an integration of requirements 
from ISO/IEC 12207 and IEC 62304 following the guidelines for process descriptions set forth in 
ISO/IEC 24774.  
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Figure 1. Building blocks of medical device software development PRM 
 
The mapping of the requirements from the two different international standards aims at integrating the 
varying underlying requirements into a more abstract set of PRM-based requirements which can be 
applied in the development of a medical device software development PAM. In this section, we outline 
the approach to mapping those processes that have distinguishable one-to-one mappings from IEC 
62304 to ISO/IEC 12207. With the exception of the IEC 62304 risk management process, the majority 
of the IEC 62304 processes are well mapped to the ISO/IEC 12207 software life cycle processes. The 
essential difference for many of these processes is that the safety critical activities are embedded 
throughout the IEC 62304 software life cycle processes.  
In conducting process mappings for the directly corresponding processes, we applied the systematic 
approach of constant comparison and memoing as described by Grounded Theory. Constant 
comparison is an iterative process of data integration where the dimensions and the properties 
specific to data are specified [19]. This iterative process is supported by keeping memos that are a 
written record of analyses. Memoing “forces the analyst to think about the data and it is in thinking that 
analysis actually occurs” [20].  
In this requirements integration activity, we conducted several iterations of constant comparison and 
memoing. In order to increase the validity of the mapping, a formal independent mapping of the 
individual processes was performed by two experienced software process researchers.  
The first iteration took place when one of the researchers conducted an initial comparison of the two 
processes (ISO/IEC 12207 and IEC 62304). The result of this first iteration was a proposed mapping 
along with detailed memos that capture the reasoning behind the proposed process mappings. The 
second researcher then conducted a review of the first comparison and took notes for the underlying 
reasons for agreeing or disagreeing with the first researcher. The researchers then reviewed all the 
data together in the third iteration of constant comparison and they memoed the review results while 
finalising the requirements integration. Additional ideas and propositions of data integration that 
occured while the researchers finalised the comparison were again memoed and reviewed by both 
researchers. Iterative cycles of constant comparison were undertaken until the researchers had no 
conflict (or no new suggestions to the agreed requirements integration). Constant comparison is a 
systematic approach to analysing and integrating the process requirements that are written using 
different terminology and concepts [19]. Memos permit the tracking of justifications for process 
integration. The memos are also crucial in the validation of the PRM as the reviewers will be able to 
follow the data analysis and integration process in great detail.  
At the time of submitting this paper, the PRM developed in the first step has been approved for 
publication by the IEC national bodies as IEC DTR 80002-3: Process Reference Model for Medical 
Device Software Life Cycle Processes (IEC 62304). IEC TR 80002-3 will be published in the middle of 
this year.  
In the second step of the PRM development, IEC 80002-3 was extended with medical device 
regulatory standards that medical device software development organisations have to adhere to. The 
requirements from the international standards ISO 14971 and ISO 13485 where then analysed and 
the requirements that were not yet in the PRM were then integrated into it. ISO 13485 is a Quality 
Management System standard setting the requirements for regulatory purposes. ISO 14971 describes 
the application of Risk Management to medical devices. Both of these standards are mandatory for 
medical device software organisations. To have a comprehensive medical device software PRM, the 
relevant requirements from these two mandatory standards were included. The approach of 
integrating requirements from different standards was carried out similarly to the one described above 
with iterations of reviews by experts until there were no more contradictions in the experts’ proposals 
for integration.  
Guidelines for 
Process 
Description: 
ISO/IEC 24774 
Software lifecycle 
processes:  
ISO/IEC 
12207:2008 
Medical device 
software lifecycle 
processes:  
IEC 62304 
Risk 
management in 
medical devices: 
ISO 14971 
Medical Device software development PRM 
Quality 
Management 
System 
Standard:  
ISO 13485 
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The resulting medical device software development PRM describes processes that could be grouped 
into three – the system life cycle processes, the software life cycle processes and the supporting pro-
cesses. ISO 13485 requirements are primarily related to the system level processes which were de-
rived from ISO/IEC 12207 in the first PRM development step. ISO 14971 maps mostly to the Software 
Risk Management process described also in IEC 62304.  
ISO 13485 sets the requirements for Quality Management System (QMS) for Medical Devices. These 
requirements were integrated into the Medical Device Software Development PAM through relevant 
new Process Outcomes where no corresponding ones already exist, or as additional details in Base 
Practices where corresponding Process Outcomes already existed. Some of the QMS requirements 
target higher Capability Levels, in which case the requirements were related to Generic Practices PA 
2.1 (e.g. on allocating resources) or to PA 2.2 (e.g. on documentation) on Capability Level 2. The 
outcomes or base practices derived from ISO 13485 were highlighted to visualize the source standard. 
This would then allow detailed feedback to companies in their compliance to the specific standards as 
a result of process assessment.  
ISO 14971 distributes the risk management related requirements across all software life cycle 
processes. To avoid major duplication, the risk management requirements were kept only in the 
Software Risk Management process of the main body of the PAM. Instead of distributing these 
requirements across life cycle processes, a table was added in the Annex of the PAM that lists the 
specific risk management requirements for each software life cycle process. These requirements need 
to be added to the selected software life cycle processes for process assessment in the case where 
the process assessment will not include the Software Risk Management process. The table in the 
Annex provides the Outcomes from ISO 14971 and their corresponding Base Practice texts from IEC 
80002-1 as well as the suggested location in the list of already existing Outcomes in each of the 
software life cycle processes. 
As a result of the integration activities described above, the medical device software  PRM consists of 
25 processes in the three sets of software life cycle processes, software support processes, and 
system life cycle processes. In the following section we describe how this PRM was extended with 
additional elements for medical device software development process assessment model (PAM). This 
PAM will allow the evaluation of software and systems development processes against all the medical 
device standards mentioned above. 
3 Development of the PAM 
The aim of the Medical Device Software Development PAM is to provide a comprehensive model for 
assessing the software and systems development processes against the widely required medical 
device regulations, standards and guidelines that a software development organisation in the medical 
device section has to adhere to. Medical Device Software Development PAM has two dimensions - 
process dimension and capability dimension. Process dimension lists three groups of processes from 
various models and standards specified below, i.e. systems life cycle processes, software life cycle 
processes, and support processes. Each process is described in terms of a Process Name, Process 
Purpose, Process Outcomes, Base Practices, Work Products and Work Product Characteristics. 
Process Outcomes are the normative requirements within a process, the achievement of which will 
allow satisfying the Process Purpose statement. Base Practices are informative activities that illustrate 
one possible way (workflow) to achieve the corresponding Process Outcomes. Work Products are 
artefacts that are either produced or used by the Base Practices, both support the achievement of the 
Process Outcome. Each Work Product is further described in terms of its content called Work Product 
Characteristics. In the case of the medical device software development PAM, some of these Work 
Products are normative as they are based on the requirements derived from IEC 62304, ISO 14971 or 
ISO 13485. Similarly, their content may have been specified in these standards, and if that is the case, 
this information has been carried forward to Work Products Characteristics of the PAM.  
Medical Device Software Development PAM includes information from the following standards and 
models. First, the baseline PAM is built upon the integrated model of IEC 62304 (Medical device 
software life cycle processes) and ISO/IEC 12207 (Software and Systems life cycle processes) – the 
PRM for IEC 62304, i.e. IEC 80002-3 and the QMS and Risk Management requirements added in the 
second step of the PRM development from ISO 13485 and ISO 14971, respectively. The Process 
Outcomes were derived from these four standards resulting in the PRM for Medical Device Software 
Development as described in the previous section. This PRM was extended with corresponding Base 
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Practices, the process implementation steps that result in the achievement of the outcomes, from IEC 
62304, ISO/IEC 15504-5 and IEC 80002-1 (for ISO 14971).  
As mentioned previously, IEC 80002-1 provides guidance on the application of ISO 14971 (Risk 
Management) to Medical Device Software. This guidance information was added to the Base practices 
to correspond to the requirements from ISO 14971 described in the normative part of the model 
illustrating a way for achieving these requirements. Most of the information from IEC 80002-1 was 
integrated into the PAM through Software Risk Management process Base Practices.  
Additional base practice information was then derived from the FDA guidance documents on 
Premarket Submission [21], Software Validation [22], and Off-The-Shelf (OTS) [23] software. In most 
cases, this guidance was integrated into the existing processes through adding onto the existing Base 
Practices and Work Products or adding new Base Practices. Software Validation is not described in a 
separate process in IEC 62304 but as the FDA guidance provides the current best practices for 
software development in medical device domain, this area should also be considered. Additional 
processes of Software Validation, Software Installation and Software Acceptance Support were 
therefore added from ISO/IEC 12207 to satisfy the requirements of the FDA Guidance Document on 
Software Validation. Best practices from the FDA guidance documents were then analysed and 
iteratively integrated into these three processes.  
Figure 2 below describes the different sources for the medical device software development PRM and 
PAM. The medical device software development PRM is based on IEC 62304, ISO/IEC 12207, ISO 
14971 and ISO 13485. The PAM then extends this PRM with base practices and work products, some 
of the latter also being normative as they are described in IEC 62304, ISO 14971 or ISO 13485 as 
requirements. Where process outcomes are derived from ISO/IEC 12207, their corresponding base 
practices and work products are derived from ISO/IEC 15504-5. Where process outcomes are derived 
from ISO 14971, their corresponding base practices are derived from IEC 80002-1. In addition to 
these sources, FDA guidance on premarket submissions, software validation and off-the-shelf 
software have been added to the informative base practices where appropriate.  
 
Figure 2. Normative and informative elements of the medical device software development 
PRM and PAM 
 
Capability dimension of the Medical Device Software Development PAM is derived directly from 
ISO/IEC 15504 together with the Capability Levels, Process Attributes, Generic Practices, Generic 
Resources and Generic Work Products. 
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4 Discussion 
One of the biggest challenges in integrating requirements and informative information from various 
sources is to do with the structure and terminology used in standards. Although ISO/IEC 24774 de-
scribes a uniform structure for process models, this has not been widely adopted quite yet. Some of 
the standards list their requirements in activities distinguishable as requirements only by the verb used 
in that sentence, e.g. “shall”, “should” or “are”.  
Natural language offered another challenge in the integration of requirements from various sources. 
Terms like “define”, “identify”, “document”, “record”, and “establish” have each got a different meaning 
in some standards but in other standards they can be all be summed up under the term “establish”. It 
took many iterations of constant comparison before reaching a result that both reviewers were satis-
fied with.  
The terminology of risk management in medical device standards has a different meaning from risk 
management in the generic software development standards where the risks are mostly related to 
project budget and schedule. In generic software development standards, safety engineering and 
safety management correspond to the product risk management central to any safety critical domain 
software development. Deciding on the terminology to adopt in the single best practice framework has 
been a great challenge. On one hand, the terminology should be the one that the safety critical do-
main experts use every day in their work as they will be applying the framework. At the same time, the 
terminology should be comprehensible for software developers across different domains allowing the 
latter to move into a safety critical software development.   
Another significant challenge in integrating various requirements from different sources is the interface 
between systems and software levels. This is a challenge often faced in embedded software 
development. In our PAM, there are both system and software life cycle processes and for embedded 
software development, the interface between these levels should be very strong. One way to 
strengthen the interface is to trace requirements from users throughout the development to validation 
ensuring that the user gets exactly what he or she needed. In order to further strengthen the interface 
between the software and system level development processes, this traceability should be bilateral, 
meaning that not only should you be able to trace the user requirements through system and software 
requirements specification to the final product, but you should also be able to trace every feature of 
the product and software item back to the user needs. 
5 Conclusions and Future Works 
The medical device software development domain is filled with regulations that software development 
organisations need to comply with in order to market their products. In this paper we have described 
these regulatory standards together with the generic software development standards, further detailing 
how we have integrated requirements from both into a best practice framework.  
This framework can be used for medical device software development process assessments on both 
system and software level. The framework provides visibility of compliance of the organisation’s 
processes with the requirements from all the source standards of the framework. This will allow the 
medical device manufacturer to select the supplier that focuses on the improvement of their medical 
device software development and adopts the best practices derived from the set of required 
standards.  
At the time of submitting this paper, the framework is being validated in industry. The framework has 
been piloted in the first medical device companies with the aim to gather feedback from medical 
device software developers and to improve the framework based on this feedback before its official 
launch later this year.  
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